Published in Vaccine Weekly, November 19th, 2008
The work, reported in the online edition of the Proceedings of the National Academy of Sciences the week of Nov. 3, could help researchers develop and test new vaccines for diseases including HIV, fungal infections and antibiotic-resistant bacterial infections.
"We're building a toolkit which we can use to look at how an immune response develops successfully. Then we aim to use that information for reverse engineering vaccines that would invoke that same type of response," said J. Christopher Love, assistant professor of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-11-19)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.